Published 1 day ago • loading... • Updated 1 day ago
Leerink Partners Forecasts Strong Price Appreciation for Amneal Pharmaceuticals (NASDAQ:AMRX) Stock
Summary by MarketBeat
1 Articles
1 Articles
Leerink Partners Forecasts Strong Price Appreciation for Amneal Pharmaceuticals (NASDAQ:AMRX) Stock
Leerink Partners increased their price target on Amneal Pharmaceuticals from $23.00 to $25.00 and gave the company an "outperform" rating in a report on Thursday.
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center1Last Updated100% Center
Bias Distribution
- 100% of the sources are Center
100% Center
C 100%
Factuality
To view factuality data please Upgrade to Premium






